The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 18, 2026
Snapshot (as of Jul 18, 2026): State Street Health Care Select Sector SPDR ETF (XLV) pays a $2.53 annual dividend ($0.66 quarterly), yielding 1.57% at $161.09/share. Next ex-dividend date 2026-06-22. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.57%
Annual Dividend: $2.53 per share
Ex-Dividend Date: 2026-06-22
Dividend Frequency: quarterly
Sector: Financial Services
Years of Dividend History: 28
The State Street Health Care Select Sector SPDR ETF dividend comes from a fund that tracks the Health Care Select Sector Index, giving investors concentrated exposure to S&P 500 healthcare companies across pharmaceuticals, biotechnology, medical equipment, and health technology. XLV currently pays a 1.55% yield, with a trailing annual dividend rate of $2.5326 per share paid quarterly. The next ex-dividend date is June 22, 2026, with the last quarterly payment of $0.6562 per share. Growth-and-income investors who want targeted healthcare sector exposure with a 10.2% dividend CAGR over 15 years are the clearest fit, given the fund's low beta of 0.56.
State Street Health Care Select Sector SPDR ETF pays out dividends as a pass-through from its underlying holdings, making a traditional payout ratio not applicable (fund/ETF). State Street Health Care Select Sector SPDR ETF dividend safety is therefore tied to the income generated by its portfolio of S&P 500 healthcare companies spanning pharmaceuticals, medical equipment, biotechnology, and life sciences, sectors with recurring demand built into their business models. The primary pressure on the payout comes from the fund's exposure to a single sector: a broad healthcare downturn, regulatory pricing pressure on pharmaceuticals, or a shift in S&P 500 index composition could reduce the income passed through to shareholders.
State Street Health Care Select Sector SPDR ETF dividend history shows a CAGR of 10.2% per year from 2010 to 2025. Per-share payments grew from $0.5770 to $2.4770 over that window (2026 is a partial year and excluded from the CAGR calculation). The largest single-year jump in the window was 61.9% in 2019, though the data also contains at least one year-over-year decline exceeding 5%, so growth has not been linear. XLV has posted five consecutive years of dividend increases through 2025.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +7.5% | $1.99 (2022) | $2.48 (2025) |
| 5-Year | +8.0% | $1.69 (2020) | $2.48 (2025) |
| 10-Year | +9.1% | $1.03 (2015) | $2.48 (2025) |
XLV fits growth-and-income investors who want healthcare sector exposure and are willing to accept a low current yield in exchange for above-average dividend growth. The yield of 1.55% is classified as low (below 2%), and it sits above the fund's own 5-year average of 1.32%, which means current buyers are getting a slightly better entry yield than the recent norm. The 10.2% annual dividend growth rate over 15 years is the defining characteristic here. What an investor gains is a fast-compounding income stream tied to a diversified basket of S&P 500 healthcare names. The trade-off is a starting yield that delivers limited near-term income.
| Payment Date | Amount per Share |
|---|---|
| 2026-06-22 | $0.6562 |
| 2026-03-23 | $0.5947 |
| 2025-12-22 | $0.6570 |
| 2025-09-22 | $0.6250 |
| 2025-06-23 | $0.6300 |
| 2025-03-24 | $0.5650 |
| 2024-12-23 | $0.6220 |
| 2024-09-23 | $0.5770 |
| 2024-06-24 | $0.5730 |
| 2024-03-18 | $0.5230 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.2510 |
| 2025 | $2.4770 |
| 2024 | $2.2950 |
| 2023 | $2.1690 |
| 2022 | $1.9920 |
Project income from XLV with the XLV dividend calculator or track your full portfolio with the dividend tracker.